ACXP · Acurx Pharmaceuticals, Inc.
AI read · Neutral
The AI's read
The filing describes a board change, not a shift in Acurx's work or plans. Scodari's advisory role keeps him connected to the company, and Acurx says his departure does not reflect a disagreement. Taken together, the notice does not change how Acurx's business looks.